Loading
HKSEHealthcareMedical - Healthcare Information Services
Latest quote
HK$3.51
−HK$0.015 · -0.43%
Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.
Latest quote
HK$3.51
−HK$0.015 · -0.43%
Regular session · HKT · Market data may be delayed.
Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.
Day range
Current HK$3.51
52-week range
Current HK$3.51
Regular session · HKT · Market data may be delayed.
Yidu Tech Inc. is a technology company that develops and deploys healthcare solutions leveraging big data and artificial intelligence. Its operations extend across Mainland China, Brunei, and other global regions. The company's business activities are categorized into four core segments: Big Data Platform and Solutions, Life Sciences Solutions, Health Management Platform and Solutions, and a segment for Other ventures. The Big Data Platform and Solutions division provides sophisticated data intelligence platforms and analytics-driven solutions. These offerings cater to hospitals, diverse healthcare institutions, regulatory bodies, and policymakers, aiming to enhance research, clinical diagnosis and treatment, and operational efficiency. This segment specifically includes the provision of DPAP/Eywa platforms for medical organizations. Through its Life Sciences Solutions segment, the company delivers analytical services that support clinical development, real-world evidence (RWE) research, and digital commercialization strategies for pharmaceutical companies, biotechnology firms, and medical device manufacturers. The Health Management Platform and Solutions segment offers health management applications and services, as well as insurance technology (InsurTech) solutions for insurance companies, agencies, and relevant regulators. This segment also includes the distribution of insurance products and the sale of pharmaceuticals and associated hardware. The Others segment encompasses the sale of computer hardware, medical devices, insurance brokerage services, and engagement in medical and computer technology development. Yidu Tech Inc. was established in 2014 and is headquartered in Beijing, China.
Day range
Current HK$3.51
52-week range
Current HK$3.51
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 790.51M CNY | 714.98M CNY | 807.08M CNY | 804.7M CNY | 1.24B CNY |
| Cost of goods sold | 502.5M CNY | 475.8M CNY | 467.63M CNY | 530.2M CNY | 840.31M CNY |
| Gross profit | 288.01M CNY | 239.18M CNY | 339.45M CNY | 274.5M CNY | 396.9M CNY |
| Research and development | 159.1M CNY | 186.48M CNY | 232.93M CNY | 342.52M CNY | 368.66M CNY |
| Selling, general, and administrative | 190.95M CNY | 285.55M CNY | 380.21M CNY | 503.63M CNY | 750.97M CNY |
| Operating expenses | 378.29M CNY | 373.33M CNY | 559.36M CNY | 979.59M CNY | 1.17B CNY |
| Interest income | 1.7M CNY | 158.83M CNY | 143.29M CNY | 78.76M CNY | 5.51M CNY |
| Interest expense | 1.87M CNY | 2.01M CNY | 3.31M CNY | 2.61M CNY | 4.21M CNY |
| Depreciation and amortization | 35.42M CNY | 43.3M CNY | 47.11M CNY | 46.35M CNY | 46.94M CNY |
| Operating income | −90.28M CNY | −134.15M CNY | −219.92M CNY | −617.6M CNY | −759.83M CNY |
| Net income | 70.15M CNY | −117.79M CNY | −194.94M CNY | −627.97M CNY | −762.32M CNY |
Company facts updated Sep 13, 2026.
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Total International Stock ETFVXUS5.27M0.00%646.2B USD0.05%$87.14+1.00%
Vanguard FTSE Emerging Markets ETFVWO4.95M0.00%162.3B USD0.06%$60.35+0.69%
iShares Core MSCI Emerging Markets ETFIEMG4.26M0.00%162.15B USD0.09%$82.57+1.21%
Vanguard FTSE All-World ex-US Small-Cap ETFVSS1.85M0.01%13.6B USD0.06%$158.56+0.72%
Avantis Emerging Markets Equity ETFAVEM805.36K—28.86B USD0.33%$95.35+1.29%
Avantis Emerging Markets Value ETFAVES381.4K0.02%1.56B USD0.36%$66.29+1.16%
State Street SPDR Portfolio Emerging Markets ETFSPEM268.87K0.00%17.86B USD0.07%$52.51+0.67%
Vanguard Total World Stock ETFVT227.87K0.00%97.9B USD0.06%$159.94+0.89%Vanguard Total International Stock ETFVXUSVanguard FTSE Emerging Markets ETFVWOiShares Core MSCI Emerging Markets ETFIEMGVanguard FTSE All-World ex-US Small-Cap ETFVSSAvantis Emerging Markets Equity ETFAVEMAvantis Emerging Markets Value ETFAVESState Street SPDR Portfolio Emerging Markets ETFSPEMVanguard Total World Stock ETFVTAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
